mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-09 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
3e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
4e-08 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
7e-08 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-08 |